Info Flashcards
(33 cards)
Effects of alpha2 antagonist
Dec BP w/o increasing the heart rate
CAUSE: 1st dose syncope
Tx for: HTN and urinary retention due to BPH
Methyldopa is a prodrug that must be converted 1st to
Alpha-Methylnorepinephrine
An irreversible alpha1&2 blocker that is used before operation for pheochromocytoma
Phenoxybenzamine
A reversible alpha1&2 blocker that is used to manage HTN due to pheochromocytoma
Phentolamine
Ion channel type (channel-linked receptor)
2 types
Receptor operated(ligand gated)
Voltage operated
Receptors for many hormones and slow transmitters
G CHON coupled receptor (metabotropic receptors)
Potency depends on
Affinity and efficacy
The rel bet receptor occupancy and its ability to initiate a response
Efficacy
The observable response can be described only in terms of an all or none event
Quantal response
Indicates potential variability of responsiveness among indvls
-info regarding safety
Quantal dose response curve
Therapetic index aka
Margin of safety
The ratio of the lethal doses to 50% of the population over the median effective dose
Therapeutic index
Excitatory transmitter of the brain and smooth muscles
NE
Released fron inhibitory neurons
5-HT
Inhibitory NT of the brain
GABA
Thought to be imp in learning, memory and brain fnxns
Excitatory amino acid
Glutamate
Ex of opioids that in time of stress and pain , they act at opiate receptors to relieve pain
Endorphins
Enkephalins
Dynorphins
Principal transmitters if ANS
Ach and NE
G CHON coupled receptors causing:
Activation of phospholipase C (IP3 and DAG)
Inh adenylate cyclase
Activation of K channels or inh Ca channels
Muscarinic receptor
Producing slow excitation of ganglia
M1 receptor (neural)
Muscarinic receptor
Causing dec in cardiac rate and force of contraction
M2 receptor (cardiac)
Muscarinic receptor
Causing secretion, contraction of visceral smooth muscle, vascular relaxation
M3 receptor (glandular)
Activates phospholipase C, thus producing IP3 abd DAG
Alpha1
Inhibit adenylate cyclase, thus decreasing cAMP fmation
Alpha 2